A development stage biotechnology company engaged in the research and clinical development of biopharmaceutical products for the diagnosis and treatment of central nervous system diseases.
| Current Price | $0.21 | Mkt Cap | $6.62M |
|---|---|---|---|
| Open | $0.00 | P/E Ratio | 4.00 |
| Prev. Close | $0.21 | Div. (Yield) | N/A (N/A) |
| Daily Range | $0.21 - $0.21 | Volume | 0 |
| 52-Wk Range | $0.01 - $0.51 | Avg. Daily Vol. | 0 |
| Subject | Recs | Author | Date |
|---|
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about ALSE.PK.
Find the members with the highest scoring picks in ALSE.PK.
See what the Wall Street professionals think, according to their public statements and filings.
